Diana Brainard Nektar Therapeutics (NKTR) insider trading activity

NKTR Quotes by TradingView

Diana Brainard is Director of NEKTAR THERAPEUTICS. Currently has a direct ownership of 28,560 shares of NKTR, which is worth approximately $26,560. The most recent transaction as insider was on Sep 16, 2022, when has been sold 10,200 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.6K
0% 3M change
0% 12M change
Total Value Held $26,560

Diana Brainard Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2022
BUY
Grant, award, or other acquisition
-
10,200 Added 26.32%
28,560 Common Stock
Nov 11 2021
BUY
Grant, award, or other acquisition
-
18,360 Added 50.0%
18,360 Common Stock

Also insider at

ALVR
Allovir, Inc. Healthcare
Chief Executive Officer
DB

Diana Brainard

Director
Waltham, MA

Track Institutional and Insider Activities on NKTR

Follow NEKTAR THERAPEUTICS and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NKTR shares.

Notify only if

Insider Trading

Get notified when an Nektar Therapeutics insider buys or sells NKTR shares.

Notify only if

News

Receive news related to NEKTAR THERAPEUTICS

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NKTR